Edward B. Jamelarin

Edward Jamelarin practices at Mercy Hospital Ardmore in Ardmore, Oklahoma, part of Mercy.

Edward Jamelarin's NPI, 1104024900, was assigned on July 3, 2007. Edward Jamelarin holds Ohio license 35.085395.

Edward Jamelarin's primary practice is Mercy Hospital Ardmore, at 1011 14th Ave NW, Ardmore, OK 73401 in Carter County. The practice phone is (580) 223-5400.

Edward Jamelarin's primary practice is Mercy Hospital Ardmore in Ardmore, Oklahoma, part of Mercy. Edward Jamelarin is also affiliated with Mercy Hospital Oklahoma City. The medical group on file is Mercy Clinic Oklahoma Communities. Dmand AI also links Edward Jamelarin to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Edward Jamelarin practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Edward Jamelarin's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Edward Jamelarin is board certified in hematology by the American Board of Internal Medicine. Edward Jamelarin is licensed in Ohio.

CMS data shows 1,884 Medicare services from Edward Jamelarin across 8 procedure codes in 2024, for 596 Medicare patients. Medicare paid $142,219 for them.

CMS counts 596 Medicare patients who saw Edward Jamelarin in 2024. The largest group is 65 to 74, with 241 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 15% are also on Medicaid. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Edward Jamelarin's median patient age at 73, with 57% women.

In 2024, Edward Jamelarin wrote 2,163 Medicare Part D claims for 322 patients. 82% of them were for generic drugs. CMS names the drug for 1,840 of them, across 40 drugs with 11 or more claims each, at $4,836,410 in total drug cost. In 2023, CMS named 1,797 claims across 47 drugs.

Edward Jamelarin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 779 general payments to Edward Jamelarin from 74 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Pfizer Inc. paid the most, $1,299.